Publications by authors named "Mario Venditti"

Claim this Profile
C
Correction: Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.
Giusy Tiseo, Valentina Galfo, Sergio Carbonara, Andrea Marino, Giovanni Di Caprio, Mario Venditti

Infection· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of multidrug resistance in cancer patients with bloodstream infections caused by Gram-negative bacilli: results from a multicentre study.
Marco Falcone, Sergio Carbonara, Andrea Marino, Giovanni Di Caprio, Anna Carretta, Mario Venditti

JAC Antimicrob Resist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.
Giusy Tiseo, Valentina Galfo, Sergio Carbonara, Andrea Marino, Giovanni Di Caprio, Mario Venditti

Infection· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study.
Klaus-Friedrich Bodmann, Stefan Hagel, Alessandra Oliva, Stefan Kluge, Alessandra Mularoni, Mario Venditti

Infect Dis Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of Fosfomycin" [Journal of Global Antimicrobial Resistance 37 (2024) 86-90].
Lorenzo Volpicelli, Sara Cairoli, Dania Al Ismail, Floriana Baisi, Federica Sacco, Mario Venditti

J Glob Antimicrob Resist· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study.
Jason A Roberts, Fekade B Sime, Jeffrey Lipman, María Patricia Hernández-Mitre, João Pedro Baptista, Mario Venditti

Intensive Care Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19.
Roberto Carnevale, Cristina Nocella, Raffaella Marocco, Paola Zuccalà, Anna Carraro, Mario Venditti

Antioxidants (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil Cathepsin G and Thrombosis in COVID-19.
Francesco Violi, Simona Bartimoccia, Roberto Cangemi, Cristina Nocella, Alessandra D'Amico, Mario Venditti

Circ Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin.
Lorenzo Volpicelli, Sara Cairoli, Dania Al Ismail, Floriana Baisi, Federica Sacco, Mario Venditti

J Glob Antimicrob Resist· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use.
Massimo Sartelli, Carlo Tascini, Federico Coccolini, Fabiana Dellai, Luca Ansaloni, Mario Venditti

World J Emerg Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study.
Mario Tumbarello, Francesca Raffaelli, Maddalena Giannella, Gennaro De Pascale, Antonio Cascio, Mario Venditti

Open Forum Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: "Caveat Emptor!": Duration of Therapy Should Not Be Set .
Alberto Enrico Maraolo, Giancarlo Ceccarelli, Mario Venditti, Alessandra Oliva

Pathogens· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Did the updated Duke criteria missed from the list of typical microorganisms causing infective endocarditis?
Lorenzo Volpicelli, Alessandra Oliva, Mario Venditti

Infez Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended.
Alessandra Oliva, Francesco Cogliati Dezza, Francesca Cancelli, Ambrogio Curtolo, Antonio Falletta, Mario Venditti

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin.
Alessandra Oliva, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Federico Pea, Maurizio Sanguinetti, Mario Venditti

Expert Rev Anti Infect Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.
Alessandra Oliva, Francesco Cogliati Dezza, Flavia Petrucci, Francesco Eugenio Romani, Matteo Morviducci, Mario Venditti

Clin Exp Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen.
Filippo Medioli, Elena Casali, Agnese Viscido, Valentina Pistolesi, Mario Venditti

J Glob Antimicrob Resist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients-Results from a Retrospective Observational Study in Intensive Care Units.
Giancarlo Ceccarelli, Francesco Alessandri, Giuseppe Migliara, Valentina Baccolini, Giovanni Giordano, Mario Venditti

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for carbapenem-resistant (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization.
Francesco Cogliati Dezza, Sara Covino, Flavia Petrucci, Federica Sacco, Agnese Viscido, Mario Venditti

JAC Antimicrob Resist· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Carbapenemase-Producing Infections: A Retrospective, Observational, 2-Center Clinical Study.
Alessandra Oliva, Laura Campogiani, Giulia Savelloni, Pietro Vitale, Alessandra Lodi, Mario Venditti

Open Forum Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network).
Marco Falcone, Giusy Tiseo, Sergio Carbonara, Andrea Marino, Giovanni Di Caprio, Mario Venditti

Clin Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin.
Alessandra Oliva, Sergio Carbonara, Vito Cianci, Massimo Crapis, Enea Gino Di Domenico, Mario Venditti

Expert Rev Anti Infect Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant-Related Infections.
Giancarlo Ceccarelli, Beatrice Perciballi, Alessandro Russo, Paolo Martini, Francesco Marchetti, Mario Venditti

Antibiotics (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin.
Lorenzo Volpicelli, Mario Venditti, Alessandra Oliva

Expert Rev Anti Infect Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study.
Jason A Roberts, Fekade Sime, Jeffrey Lipman, Maria Patricia Hernández-Mitre, João Pedro Baptista, Mario Venditti

Crit Care Resusc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis